Dow Up, Profusa Up

All three major indices rose today.

The NASDAQ rose 117.16 points.

The DOW rose 165.21 points.

The S&P rose 29.14 points.

Stocks edged higher in tentative trading as investors weighed continued uncertainty tied to the U.S.-Iran conflict and the risk of further disruption to oil flows through the Strait of Hormuz. Oil prices swung during the session, but the broader market still finished modestly higher, suggesting investors were willing to add risk cautiously despite the geopolitical backdrop.

The move higher reflected a restrained but positive tone rather than a broad relief rally. With the market still sensitive to developments in energy prices and Middle East tensions, gains in the major indices pointed to measured optimism rather than a full shift away from defensive positioning.

All this as Profusa shares rose 1.09 points to end the day at $1.85 per share. Profusa's previous close was $0.758, and Stock Analysis shows the stock closed at $1.85 on April 6, 2026, a gain of $1.092, which rounds to $1.09.

Profusa's surge was news-driven. On April 6, the company announced a $30 million letter of intent tied to a PanOmics platform expansion and also said it launched a Mayo Clinic partnership aimed at advancing pancreatic cancer applications alongside its Lumee real-time biochemistry monitoring platform. That announcement gives investors a concrete catalyst for the sharp move higher, rather than leaving the gain to be explained only by speculative trading.

The size of the rally was also amplified by Profusa's small-cap structure. More than 239 million shares traded on the day, far above the company's usual activity, which indicates a burst of buying interest that likely magnified the price move once the news hit the market.